Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY2623091 in Primary Hypertension
NCT02194465Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2014
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of LY-2623091 in primary hypertension, sponsored by Eli Lilly and Company. Started Aug 2014; status: completed.
02
Drugs
LY-2623091
03
Conditions
primary hypertension
Beyond the preview
Go deeper on NCT02194465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02194465.